» Authors » Vincent Duronio

Vincent Duronio

Explore the profile of Vincent Duronio including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 1298
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mousavizadeh R, Waugh C, DeBruin E, McCormack R, Duronio V, Scott A
BMC Musculoskelet Disord . 2023 Mar; 24(1):197. PMID: 36927534
Background: Previous studies have shown that patients with hypercholesterolemia experience elevated levels of oxidized LDL (oxLDL), a molecule which triggers inflammation and collagenase activity. In this study we discovered novel...
2.
Mousavizadeh R, Hojabrpour P, Eltit F, McDonald P, Dedhar S, McCormack R, et al.
Sci Rep . 2020 Jul; 10(1):12644. PMID: 32724089
Tendons are specialized tissues composed primarily of load-responsive fibroblasts (tenocytes) embedded in a collagen-rich extracellular matrix. Habitual mechanical loading or targeted exercise causes tendon cells to increase the stiffness of...
3.
Ouro A, Arana L, Riazy M, Zhang P, Gomez-Larrauri A, Steinbrecher U, et al.
Exp Cell Res . 2017 Oct; 361(2):277-283. PMID: 29080796
The bioactive sphingolipid ceramide 1-phosphate (C1P) regulates cell division in a variety of cell types including macrophages. However, the mechanisms involved in this action are not completely understood. In the...
4.
Jamil S, Mousavizadeh R, Roshan-Moniri M, Tebbutt S, McCormack R, Duronio V, et al.
Med Sci Sports Exerc . 2017 Apr; 49(9):1769-1777. PMID: 28398948
Purpose: Angiopoietin-like 4 (ANGPTL4) is known to play a variety of roles in the response to exercise, and more recently has been shown to enhance the healing of tendon, a...
5.
Jamil S, Hojabrpour P, Duronio V
Biochem Biophys Res Commun . 2016 Nov; 482(1):154-158. PMID: 27833016
p53 is a tumor suppressor protein which is either lost or inactivated in a large majority of tumors. The small molecule 2-phenylethynesulfonamide (PES) was originally identified as the inhibitor of...
6.
Mousavizadeh R, Scott A, Lu A, Ardekani G, Behzad H, Lundgreen K, et al.
J Physiol . 2015 Dec; 594(11):2971-83. PMID: 26670924
Key Points: Angiopoietin-like 4 (ANGPTL4) modulates tendon neovascularization. Cyclic loading stimulates the activity of transforming growth factor-β and hypoxia-inducible factor 1α and thereby increases the expression and release of ANGPTL4...
7.
Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al.
J Cell Physiol . 2015 Nov; 231(6):1350-63. PMID: 26529564
It has long been realized that hematopoietic cells may have the capacity to trans-differentiate into non-lymphohematopoietic cells under specific conditions. However, the mechanisms and the factors for hematopoietic cell trans-differentiation...
8.
Wang S, Hojabrpour P, Zhang P, Kolesnick R, Steinbrecher U, Gomez-Munoz A, et al.
Biochim Biophys Acta . 2015 Aug; 1851(11):1482-9. PMID: 26253821
The survival of macrophages depends on the presence of specific cytokines that activate survival signaling events, as well as suppressing formation of apoptosis-inducing pathways. We have previously shown that macrophages...
9.
Jamil S, Lam I, Majd M, Tsai S, Duronio V
Cancer Cell Int . 2015 Aug; 15:79. PMID: 26251638
Background: Etoposide has been used clinically in cancer treatment, as well as in numerous research studies, for many years. However, there is incomplete information about its exact mechanism of action...
10.
Zhang P, Riazy M, Gold M, Tsai S, McNagny K, Proud C, et al.
Can J Cardiol . 2014 Dec; 30(12):1684-8. PMID: 25475470
We tested whether loss of eukaryotic elongation factor 2 kinase (eEF2K) activity in macrophages suppresses development of atherosclerosis by transplanting bone marrow from mice with mutant eEF2K into ldlr(-/-) mice....